| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.7M | +201.7% |
| Cost of Revenue | $8.2M | +56.4% |
| R&D Expense | $48.3M | +30.4% |
| SG&A Expense | $79.6M | +17.6% |
| Operating Income | -$123.3M | -16.7% |
| Income Tax | $0 | — |
| Net Income | -$75.5M | -15.9% |
| EPS (Basic) | -$0.54 | +5.3% |
| EPS (Diluted) | -$0.54 | +5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.3M | -71.5% |
| Short-term Investments | $11.0M | +119.2% |
| Accounts Receivable | $6.9M | +287.0% |
| Current Assets | $73.0M | -60.6% |
| Total Assets | $95.1M | -51.8% |
| Current Liabilities | $49.4M | +4.8% |
| Long-term Debt | $38.3M | -8.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$113.9M | -4.4% |
| Capital Expenditures | $3.5M | +5.9% |
| Investing Cash Flow | -$9.5M | -428.0% |
| Financing Cash Flow | $2.2M | -98.7% |
| Free Cash Flow | -$117.4M | -4.5% |
| Total Liabilities |
| $64.5M |
| -39.5% |
| Stockholders' Equity | $30.6M | -66.2% |